QVT Financial
http://www.qvt.com/mainpage.htmlQVT Financial LP is a hedge fund management company. Since the firm’s inception, the core team has spent its time working together to develop and implement innovative, fundamental and quantitatively-oriented trading strategies.
View Older Stories View More Recent Stories
-
Unusual 11 Mid-Day Movers 8/19: (CLTX) (HILL) (ACI) Higher; (RYAM) (TEDU) (FLXS) Lower
-
Celsus Therapeutics (CLTX), Volution Immuno Announce $75M Private Placement
-
Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement
-
Form 13F-HR QVT Financial LP For: Jun 30
-
Palatin Technologies Completes $30 Million Financing
-
Molycorp (MCP) Enters Restructuring Agreement with Creditors Covering $1.7B of Debt
-
Molycorp, Inc. Signs Restructuring Support Agreement With Key Creditors; Agreement Covers More Than 70% of 10% Secured Noteholders
-
Molycorp, Inc. Signs Restructuring Support Agreement With Key Creditors; Agreement Covers More Than 70% of 10% Secured Noteholders
-
REGENXBIO Secures $70.5 Million in a Mezzanine Financing
-
REGENXBIO Secures $70.5 Million in a Mezzanine Financing
-
Form 13F-HR QVT Financial LP For: Mar 31
-
Form SC 13G AEHR TEST SYSTEMS Filed by: QVT Financial LP
-
Aehr Test Systems Completes Convertible Debt Financing With Strategic Investor
-
Aehr Test Systems Completes Convertible Debt Financing With Strategic Investor
-
Form SC 13D TEKMIRA PHARMACEUTICALS Filed by: QVT Financial LP
-
Tekmira Announces Completion of the Merger With OnCore Creating a Leading Hepatitis B Solutions Company
-
Form SC 13G/A Retrophin, Inc. Filed by: QVT Financial LP
-
Form SC 13G/A TENGION INC Filed by: QVT Financial LP
-
Form SC 13G/A PALATIN TECHNOLOGIES Filed by: QVT Financial LP
-
Form 13F-HR QVT Financial LP For: Dec 31
-
Form SC 13G/A DHT Holdings, Inc. Filed by: QVT Financial LP
-
Form SC 13G/A ARROWHEAD RESEARCH CORP Filed by: QVT Financial LP
-
Form SC 13G/A Oncothyreon Inc. Filed by: QVT Financial LP
-
Form SC 13G/A Mirati Therapeutics, Filed by: QVT Financial LP
-
Form SC 13G/A VIVUS INC Filed by: QVT Financial LP
-
Form SC 13G/A CYTRX CORP Filed by: QVT Financial LP
-
Form SC 13G/A REPROS THERAPEUTICS INC. Filed by: QVT Financial LP
-
Form SC 13G/A Ocera Therapeutics, Inc. Filed by: QVT Financial LP
-
Form SC 13G/A Orexigen Therapeutics, Filed by: QVT Financial LP
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: QVT Financial LP
-
QVT Financial LP Lowers Stake in AGENUS (AGEN) to 9.82%
-
Form SC 13G/A AGENUS INC Filed by: QVT Financial LP
-
Form SC 13G ASSEMBLY BIOSCIENCES, Filed by: QVT Financial LP
-
Form 13F-HR QVT Financial LP For: Sep 30
-
QVT Financial Raises Stake in Arrowhead Research (ARWR) to 7.62%
-
Form SC 13G/A ARROWHEAD RESEARCH CORP Filed by: QVT Financial LP
-
Form SC 13G/A DHT Holdings, Inc. Filed by: QVT Financial LP
-
Form SC 13D PEREGRINE SEMICONDUCTOR Filed by: QVT Financial LP
-
QVT Financial Lowers Stake in Achillion Pharma (ACHN) to 5.2%
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: QVT Financial LP
-
Form 13F-HR QVT Financial LP For: Jun 30
-
QVT Associates Sells 1.8M Achillion Pharma (ACHN) Shares
-
UPDATE: QVT Financial Shows 9.3% Stake in CYTRX (CYTR)
-
QVT Financial Shows New 5.77% Stake in Oncothyreon, Inc. (ONTY)
-
QVT Financial Pleased with VIVUS (VVUS) Settlement; Changes Filing to 13G
-
QVT Financial Purchase $20M of Convertible Debt Issued by VIVUS (VVUS)
-
StreetInsider.com Pre-Open Movers 11/16: (PENN) (SHF) (OMX) Higher; (DVAX) (SHLD) (SINA) Lower (more...)
-
StreetInsider.com After-Hours Movers 11/15: (SHF) (ARUN) (GPS) Higher; (DVAX) (SHLD) (SINA) Lower (more...)
-
QVT Financial Lowers Stake in Vivus, Inc. (VVUS) to 8.3%; Says Company Should Be Sold
-
QVT Financial Shows New 8.07% Stake in Achillion Pharmaceuticals, Inc. (ACHN)

